DOT1L Inhibition Sensitizes MLL-Rearranged AML to Chemotherapy

Wei Liu(Baylor College of Medicine), Michele S. Redell(Baylor College of Medicine)

PLoS ONE

May 23, 2014

10.1371/journal.pone.0098270

Cited by 73

Related Papers

Stat3 signaling in acute myeloid leukemia: ligand-dependent and -independent activation and induction of apoptosis by a novel small-molecule Stat3 inhibitor

|Blood|2011|261

Repurposing Atovaquone as a Therapeutic against Acute Myeloid Leukemia (AML): Combination with Conventional Chemotherapy Is Feasible and Well Tolerated

|Cancers|2023|18

Aberrantly low STAT3 and STAT5 responses are associated with poor outcome and an inflammatory gene expression signature in pediatric acute myeloid leukemia

|Clinical & Translational Oncology|2021|8